| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $194K | — | — |
| SG&A Expense | $65K | — | +18.8% |
| Interest Expense | $154K | — | +115.0% |
| Net Income | -$2.0M | — | +15.8% |
| EPS (Basic) | -$0.09 | — | +40.0% |
| EPS (Diluted) | -$0.09 | — | +40.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.6M | — | -30.3% |
| Short-term Investments | $1.1M | — | — |
| Current Assets | $4.5M | — | — |
| Total Assets | $12.2M | — | — |
| Current Liabilities | $17.6M | — | — |
| Total Liabilities | $17.7M | — | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.0M | — | — |
| Investing Cash Flow | -$6.1M | — | — |
| Financing Cash Flow | $6.7M | — | — |
| Stockholders' Equity | -$5.5M | -54.1% | +51.4% |